Get the Stockscreener App
21.48
5.45%
1.11
After Hours:
21.48
Nanobiotix Adr Stock (NBTX) Forecast
The Nanobiotix Adr (NBTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.7859, representing a -82.37% decrease from the current price of $21.48. The highest analyst price target is $4.0226, and the lowest is $3.5492.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NBTX Price Target
Average 2.4732
(-88.49% Downside)
Is Nanobiotix Adr (NBTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.52 | Neutral |
| STOCH(9,6) | 26.08 | Neutral |
| STOCHRSI(14) | 36.59 | Neutral |
| MACD(12,26) | 0.0306 | Sell |
| ADX(14) | 12.12 | Neutral |
| William %R | -59.74 | Neutral |
| CCI(14) | -109.37 | Sell |
Buy: 0
Sell: 2
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
22.11
Sell
|
21.76
Sell
|
| MA20 |
22.20
Sell
|
21.86
Sell
|
| MA50 |
21.07
Buy
|
20.99
Buy
|
| MA100 |
18.29
Buy
|
18.21
Buy
|
| MA200 |
11.42
Buy
|
13.95
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, NBTX could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on NBTX, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 48.52 indicates that NBTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.08 indicates that NBTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 36.59 indicates that NBTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 12.12 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -109.37 indicates that NBTX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term NBTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nanobiotix Adr financial reports and earnings history, Nanobiotix Adr (NBTX) stock could reach $10.80 by 2030, $36.58 by 2040 and $24.06 by 2050. See the projected annual prices until 2050 of the Nanobiotix Adr stock below:
- Nanobiotix Adr (NBTX) is expected to reach an average price of $6.9486 in 2035, with a high prediction of $8.8719 and a low estimate of $7.7285. This indicates an $-67.65% rise from the last recorded price of $21.48.
- Nanobiotix Adr (NBTX) stock is projected to chart a bullish course in 2040, with an average price target of $36.62, representing an $70.48% surge from its current level. The forecast ranges from a conservative $36.62 to a sky-high $36.58.
- Our analysts predict Nanobiotix Adr (NBTX) to jump 79.04% by 2045, soaring from $38.47 to an average price of $38.46, potentially reaching $38.66. While $38.47 is the low estimate, the potential upside is significant.
- Nanobiotix Adr (NBTX) stock is expected to climb by 2050, reaching an average of $24.26, a $12.96% jump from its current level. However, a wide range of estimates exists, with high and low targets of $24.06 and $24.48, respectively, highlighting the market's uncertainty.
Nanobiotix Adr Stock (NBTX) Year by Year Forecast
Nanobiotix Adr Stock (NBTX) Price Forecast for 2026
The predicted value for Nanobiotix Adr (NBTX) in 2026 is set at an average of $2.7115. Estimates vary from a peak of $4.3959 to a trough of $1.0272, indicating an -87.38% surge from the present price of $21.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2026 | $3.2542 | $3.5492 | $4.0226 | -84.85% |
| March, 2026 | $3.34 | $3.7437 | $3.6759 | -84.45% |
| April, 2026 | $3.8393 | $3.5526 | $3.3748 | -82.13% |
| May, 2026 | $3.3982 | $3.4853 | $3.3982 | -84.18% |
| June, 2026 | $3.2221 | $3.1349 | $3.1349 | -85.00% |
| July, 2026 | $2.5775 | $2.9715 | $3.0522 | -88.00% |
| August, 2026 | $2.8971 | $2.7449 | $2.5071 | -86.51% |
| September, 2026 | $2.99 | $2.9982 | $3.036 | -86.08% |
| October, 2026 | $2.7181 | $2.7771 | $2.776 | -87.35% |
| November, 2026 | $0.4639 | $2.4775 | $2.5515 | -97.84% |
| December, 2026 | $0.9972 | $1.0272 | $1.1851 | -95.36% |
Nanobiotix Adr Stock (NBTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nanobiotix Adr (NBTX) is $2.7734, with a high forecast of $5.4639 and a low forecast of $0.0828. This indicates an -87.09% decrease from the last price of $21.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.8061 | $0.9239 | $0.5794 | -96.25% |
| February, 2027 | $2.075 | $0.4805 | $4.7949 | -90.34% |
| March, 2027 | $5.1139 | $1.4706 | $5.4639 | -76.19% |
| April, 2027 | $4.032 | $3.5017 | $5.2017 | -81.23% |
| May, 2027 | $1.4661 | $0.9861 | $4.2528 | -93.17% |
| June, 2027 | $0.8049 | $0.0828 | $1.6794 | -96.25% |
| July, 2027 | $0.916 | $0.3583 | $1.1927 | -95.74% |
| August, 2027 | $2.5371 | $0.5716 | $3.2094 | -88.19% |
| September, 2027 | $3.046 | $1.9582 | $4.3325 | -85.82% |
| October, 2027 | $2.5971 | $1.8271 | $3.4538 | -87.91% |
| November, 2027 | $2.6982 | $1.6849 | $2.9004 | -87.44% |
| December, 2027 | $1.3471 | $1.0671 | $2.5037 | -93.73% |
Nanobiotix Adr Stock (NBTX) Price Forecast for 2028
In 2028, Nanobiotix Adr (NBTX) is projected to reach an average price of $4.738, with a high projection of $7.8459 and a low estimate of $1.63. This indicates an -77.94% fall from the last price of $21.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.24 | $1.63 | $4.20 | -75.61% |
| February, 2028 | $3.1778 | $3.7578 | $5.1245 | -85.21% |
| March, 2028 | $5.184 | $4.3912 | $4.4001 | -75.87% |
| April, 2028 | $6.5519 | $6.2734 | $5.4179 | -69.50% |
| May, 2028 | $4.7401 | $5.8135 | $5.6223 | -77.93% |
| June, 2028 | $4.6579 | $5.3779 | $5.3935 | -78.31% |
| July, 2028 | $5.9957 | $4.3133 | $5.0357 | -72.09% |
| August, 2028 | $5.1967 | $5.9936 | $6.0947 | -75.81% |
| September, 2028 | $6.533 | $6.6164 | $6.4058 | -69.59% |
| October, 2028 | $5.6036 | $5.6036 | $6.7603 | -73.91% |
| November, 2028 | $7.8859 | $7.3254 | $7.8459 | -63.29% |
| December, 2028 | $8.4237 | $6.6292 | $6.3803 | -60.78% |
Nanobiotix Adr Stock (NBTX) Price Forecast for 2029
The 2029 price forecast for Nanobiotix Adr Stock (NBTX) is $10.70 on average, with a high prediction of $12.31 and a low estimate of $9.0971. This represents an -50.17% decrease from the previous price of $21.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.9959 | $9.2981 | $9.5759 | -53.46% |
| February, 2029 | $10.07 | $10.45 | $10.40 | -53.10% |
| March, 2029 | $10.23 | $9.0971 | $8.9371 | -52.37% |
| April, 2029 | $9.3494 | $9.3494 | $9.966 | -56.47% |
| May, 2029 | $10.08 | $9.9383 | $10.29 | -53.07% |
| June, 2029 | $10.39 | $10.08 | $9.7594 | -51.63% |
| July, 2029 | $11.32 | $10.80 | $11.01 | -47.29% |
| August, 2029 | $12.05 | $11.13 | $11.56 | -43.88% |
| September, 2029 | $12.26 | $12.39 | $12.26 | -42.94% |
| October, 2029 | $11.60 | $12.31 | $12.31 | -45.98% |
| November, 2029 | $11.24 | $11.24 | $11.18 | -47.68% |
| December, 2029 | $10.97 | $11.02 | $11.25 | -48.93% |
Nanobiotix Adr Stock (NBTX) Price Forecast for 2030
Nanobiotix Adr Stock (NBTX) is expected to reach an average price of $6.3982 in 2030, with a high forecast of $10.80 and a low forecast of $1.9967. This signifies an -70.21% decrease from the last price of $21.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.59 | $10.78 | $10.80 | -50.71% |
| February, 2030 | $10.54 | $10.53 | $10.60 | -50.95% |
| March, 2030 | $9.9431 | $9.9431 | $10.22 | -53.71% |
| April, 2030 | $9.2669 | $9.6819 | $9.9859 | -56.86% |
| May, 2030 | $9.3531 | $9.4898 | $9.2142 | -56.46% |
| June, 2030 | $9.4708 | $9.4708 | $9.592 | -55.91% |
| July, 2030 | $8.8431 | $8.8068 | $9.1809 | -58.83% |
| August, 2030 | $7.631 | $7.6566 | $8.1376 | -64.47% |
| September, 2030 | $6.9948 | $7.0388 | $7.25 | -67.44% |
| October, 2030 | $5.2311 | $6.2811 | $6.4533 | -75.65% |
| November, 2030 | $3.9889 | $3.6944 | $3.4144 | -81.43% |
| December, 2030 | $1.8567 | $1.9967 | $1.9933 | -91.36% |
28.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):